Jubilant Organosys Ltd. and Draxis Health, Inc. have entered into an agreement whereby Jubilant will acquire all outstanding common shares of Draxis for approximately $255 million.     Mr. Shyam S. Bhartia, chairman and managing director of Jubilant, and Mr. Hari S. Bhartia, co-chairman and managing director of Jubilant, commented, “Draxis represents a unique opportunity in the North American market, offering Jubilant entry into the attractive, regulated, high growth and high margin rad...